
Apply for the Specialised Pro-Resolving Mediators PhD at Queen Mary University of London. Explore eligibility, research skills, and application details.
Specialised Pro-Resolving Mediators PhD in UK
The Specialised Pro-Resolving Mediators PhD at Queen Mary University of London offers a research opportunity for candidates interested in inflammation, haematopoiesis, pharmacology and molecular medicine. The project, supervised by Professor Jesmond Dalli, focuses on understanding how specialised pro-resolving mediators affect blood-cell production in rheumatoid arthritis and cardiovascular disease.
The research will examine abnormalities in bone-marrow resolution pathways and investigate whether selected mediators can help restore a healthier balance between inflammatory and reparative myeloid-cell production.
Specialised Pro-Resolving Mediators PhD: Scholarship Overview
This doctoral research project is hosted by Queen Mary University of London in London, United Kingdom.
| Detail | Information |
|---|---|
| Research Project | Specialised pro-resolving mediators as regulators of haematopoiesis in rheumatoid arthritis and cardiovascular disease |
| Supervisor | Professor Jesmond Dalli |
| Host Institution | Queen Mary University of London |
| Location | London |
| Country | United Kingdom |
| Degree Level | PhD |
| Research Areas | Immunology, haematology, cell biology, pharmacology, molecular medicine |
| MSc Requirement | Required |
| English Requirement | Fluent English |
| Application Deadline | Not specified |
| Application Fee | Not specified |
| Funding Amount | Not specified |
Applicants should verify the latest recruitment and funding information through the official programme or application information before submitting an application.
About the Research Project
The project investigates the role of specialised pro-resolving mediators in controlling haematopoietic stem and progenitor-cell activity.
Haematopoiesis is the process through which blood cells are produced. During chronic inflammatory diseases, changes in this process can contribute to the production of inflammatory myeloid cells and may help sustain systemic inflammation.
The research will focus particularly on rheumatoid arthritis and cardiovascular disease. It aims to:
- Investigate how specialised pro-resolving mediators regulate stem and progenitor-cell activity.
- Examine the production of inflammatory and reparative myeloid cells.
- Identify disease-associated defects in bone-marrow resolution pathways.
- Test selected mediators for their ability to restore balanced haematopoietic output.
- Investigate approaches for reducing systemic inflammation.
- Develop translational biomarkers associated with altered haematopoiesis.
The project combines fundamental biological research with potential translational applications in inflammatory and cardiovascular disease.
Research Skills and Background Required
The Specialised Pro-Resolving Mediators PhD is aimed at applicants with a relevant scientific background.
Candidates should have a background in one or more of the following areas:
- Immunology
- Haematology
- Cell biology
- Pharmacology
- Molecular medicine
Relevant laboratory experience is also valuable. The project specifically identifies experience with:
- Flow cytometry
- Primary-cell culture
- Molecular biology
Applicants should also demonstrate an interest in:
- Bone-marrow biology
- Inflammation
- Lipid mediators
A strong academic record and relevant research experience are important components of the candidate profile.
Skills You Can Gain During the Specialised Pro-Resolving Mediators PhD
The project provides exposure to a broad range of experimental and translational research techniques.
Researchers will develop experience in:
Haematopoietic Stem and Progenitor Cells
Training will include the isolation and phenotyping of haematopoietic stem and progenitor cells. This provides practical experience in studying blood-cell development and regulation.
Multiparameter Flow Cytometry
Researchers will use multiparameter flow cytometry to characterise cell populations and investigate changes in haematopoietic and myeloid-cell phenotypes.
Cell and Differentiation Models
The project includes:
- Colony-forming assays
- Bone-marrow models
- Myeloid differentiation models
These approaches can help investigate how disease and inflammatory signalling influence blood-cell production.
Disease Models
The project involves experimental models related to:
- Rheumatoid arthritis
- Cardiovascular disease
This provides an opportunity to investigate inflammatory mechanisms in disease-relevant experimental systems.
Pro-Resolving Mediator Pharmacology
A major component of the research is specialised pro-resolving mediator pharmacology. Students will investigate how these mediators may influence inflammation and haematopoietic activity.
Transcriptomic Profiling and Biomarkers
The project also includes transcriptomic profiling and the development of translational biomarkers associated with altered haematopoiesis.
Eligibility Criteria
Applicants should carefully check the eligibility conditions before applying.
The stated requirements include:
- A MSc degree in Life Sciences, or completion of an MSc degree by October 2026.
- Completion of a research internship with relevant expertise.
- High grades during previous studies.
- Fluency in English.
- Some applicants may be required to provide language certification depending on their country; applicants will be informed following shortlisting.
- The applicant must not have resided in the country of the recruiting organisation for more than 12 months during the period preceding the recruitment date.
Meeting the academic requirements does not necessarily guarantee selection, as candidates are expected to demonstrate relevant research experience and suitability for the project.
Eligible Countries
The supplied project information does not provide a specific list of eligible nationalities.
Eligible countries: Not specified.
Applicants should check the official programme rules to determine whether their nationality and residency history meet the recruitment requirements.
The 12-month residency condition is particularly important. Candidates should carefully consider where they have lived during the period preceding recruitment.
Available Research Fields
This doctoral project is particularly relevant to students and researchers interested in:
- Pharmacology
- Immunology
- Haematology
- Cell biology
- Molecular medicine
- Inflammation
- Bone-marrow biology
- Lipid mediators
- Cardiovascular disease
- Rheumatoid arthritis
- Haematopoietic stem and progenitor cells
Applicants whose previous research experience overlaps with these areas may find the project especially relevant.
Required Documents
The supplied scholarship information does not provide a complete document checklist.
Required documents: Not specified.
Applicants should consult the official application instructions for the current recruitment round before preparing their submission.
Candidates should not assume that specific documents are required unless they are listed in the official application instructions.
English Language Requirements
Applicants are required to be fluent in English.
The project information also states that applicants from some countries may need to provide a language certification. The specific certification requirements will be communicated to applicants after shortlisting.
Therefore, candidates should not assume that IELTS is either universally required or universally waived for this project.
IELTS requirement: Not specifically stated in the supplied information.
Application Deadline
The application deadline for this project is not specified in the supplied information.
Because doctoral vacancies can have recruitment-specific closing dates, prospective applicants should check the official application information before preparing their final application.
How to Apply
Candidates interested in the Specialised Pro-Resolving Mediators PhDshould review the official project and recruitment information associated with Queen Mary University of London.
A sensible application process is:
- Review the project requirements and confirm that your academic background matches the stated criteria.
- Check the MSc requirement, including the condition allowing completion by October 2026.
- Review your research experience, particularly experience involving relevant laboratory techniques.
- Prepare your academic and research documents according to the official application instructions.
- Check English-language requirements based on your country and circumstances.
- Review the residency condition, particularly the 12-month restriction.
- Submit the application through the official route specified for the project.
- Ensure all information is accurate before final submission.
The official application route should always be used rather than relying solely on information reproduced on third-party scholarship websites.
Selection Process
The supplied information does not provide a detailed selection procedure.
However, the stated candidate profile indicates that academic performance, relevant research experience, scientific background and English proficiency are important considerations.
Candidates can strengthen their application by clearly demonstrating how their previous research and laboratory experience relates to the proposed work on inflammation, haematopoiesis and specialised pro-resolving mediators.
Important Tips for Applicants
1. Connect Your Previous Research to the Project
Do not simply list laboratory techniques. Explain how your previous research prepared you for this particular project.
Experience in pharmacology, inflammatory pathways, cell-based research or experimental disease models can be presented in the context of the proposed research.
2. Highlight Relevant Laboratory Experience
If you have experience with flow cytometry, cell culture, molecular biology or related techniques, describe your level of experience clearly.
3. Demonstrate Research Independence
A strong Specialised Pro-Resolving Mediators PhD application should demonstrate that you understand scientific research rather than simply having completed laboratory tasks.
Mention relevant research questions, experimental design, data interpretation and scientific outputs where applicable.
4. Read the Residency Requirement Carefully
The requirement concerning residence in the recruiting country is an important eligibility condition. Candidates should verify their own residency history against the official recruitment rules.
5. Verify the Current Deadline
Since the supplied information does not state an application deadline, check the official vacancy information before submitting your application.
Frequently Asked Questions
Who can apply for this Specialised Pro-Resolving Mediators PhD project?
Applicants should have an MSc in Life Sciences or expect to complete an MSc by October 2026. Relevant research experience, high academic grades and English fluency are also required.
What is the research topic?
The project studies how specialised pro-resolving mediators regulate haematopoiesis and inflammatory versus reparative myeloid-cell production in rheumatoid arthritis and cardiovascular disease.
Where is the Specialised Pro-Resolving Mediators PhD based?
The project is hosted by Queen Mary University of London in London, United Kingdom.
Who is the supervisor?
The project is supervised by Professor Jesmond Dalli.
Is IELTS required?
The supplied information does not specifically state that IELTS is mandatory. Applicants must be fluent in English, while some countries may require language certification. Further information is communicated following shortlisting.
What MSc degree is required?
Applicants should have an MSc in Life Sciences, or obtain the degree by October 2026.
Is previous research experience required?
Yes. The eligibility information states that applicants should have completed a research internship with relevant expertise.
What research techniques can students learn?
The project includes training in haematopoietic stem and progenitor-cell isolation and phenotyping, multiparameter flow cytometry, colony-forming assays, bone-marrow and myeloid differentiation models, specialised pro-resolving mediator pharmacology, transcriptomic profiling and translational biomarker development.
Is the funding amount specified?
No. The supplied project information does not state a scholarship amount, stipend or other specific financial benefit.
What is the application deadline?
The deadline is not specified in the supplied information. Applicants should check the official recruitment page for the current deadline.
Conclusion
The Specialised Pro-Resolving Mediators PhD at Queen Mary University of London is a research opportunity focused on the intersection of inflammation, haematopoiesis, pharmacology and cardiovascular and rheumatoid disease.
The project may be particularly relevant to applicants with backgrounds in pharmacology, immunology, haematology, cell biology or molecular medicine and research experience involving techniques such as flow cytometry, primary-cell culture or molecular biology.
Before applying, candidates should carefully verify the current recruitment information, particularly the MSc requirement, English-language conditions, residency restriction, application deadline and funding details.